TMCnet News
Robbins Arroyo LLP Is Investigating the Officers and Directors of Lannett Company, Inc. (LCI) on Behalf of ShareholdersShareholder rights law firm Robbins Arroyo LLP is investigating whether certain officers and directors of Lannett Company, Inc. (NYSE: LCI) breached their fiduciary duties to shareholders. Lannett develops, manufactures, and distributes generic versions of brand pharmaceutical products in the United States. View this press release on the firm's Shareholder Rights Blog: https://www.robbinsarroyo.com/lannett-co/ Lannett Accused of Colluding With its Peers to Fix Generic Drug Prices Investors of Lannett filed a securities class action complaint against the company's officers and directors for alleged violtions of the Securities Exchange Act of 1934 between May 9, 2013 and November 3, 2016. According to the complaint, Lannett conspired with its industry peers to fix the prices of at least four of the company's generic drugs in order to reap higher profits and secure the financing needed to make a series of massive acquisitions. The extent of Lannett's fraud was first revealed on July 16, 2014, when Lannett disclosed that it received an inquiry from the Connecticut Attorney General regarding its pricing of Digoxin. Lannett officials maintained that the company had done nothing wrong while Lannett continued to become the focus of multiple government investigations. On November 3, 2016, Bloomberg (News - Alert) reported that Lannett was being investigated by the U.S. Department of Justice for suspected price collusion, causing the company's stock to fall to $17.25 per share that day. Lannett's stock has yet to recover to its class period high of $71.15 per share. Lannett Shareholders Have Legal Options Concerned shareholders who would like more information about their rights and potential remedies can contact attorney Leonid Kandinov at (800) 350-6003, [email protected], or via the shareholder information form on the firm's website. Robbins Arroyo LLP is a nationally recognized leader in shareholder rights law. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested. Attorney Advertising. Past results do not guarantee a similar outcome. View source version on businesswire.com: http://www.businesswire.com/news/home/20171212006296/en/ |
